Drug Profile
Amoxicillin/clavulanic acid controlled release - Avadel Pharmaceuticals
Alternative Names: Amoxicillin CR/clavulanic acid IR; Co-amoxyclav XR; Long-acting amoxicillin clavulanateLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Flamel Technologies
- Class 2 ring heterocyclic compounds; Antibacterials; Azetidines; Beta-lactams; Carboxylic acids; Oxazolidinones; Penicillins; Small molecules
- Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Infections
Most Recent Events
- 24 Jan 2017 Discontinued - Phase-I for Infections in France (PO) (Avadel Pharmaceuticals pipeline, January 2017)
- 23 Oct 2012 Amoxicillin/clavulanic acid controlled release - Flamel Technologies is available for licensing http:www.flamel.com
- 16 Nov 2010 No development reported - Phase-I for Infections in France (PO)